Parallel Advisors, LLC
- SEC CIK
- 0001690010
- Latest filing
- Aug 5, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −7−100.0% | Sold out | Holders |
| Q4 2025 | 7 | $29 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 7 | $34 | <0.1% | +7 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −393−100.0% | Sold out | Holders |
| Q1 2025 | 393 | $2.20K | <0.1% | +75+23.6% | Added | Holders |
| Q4 2024 | 318 | $2.15K | <0.1% | +156+96.3% | Added | Holders |
| Q3 2024 | 162 | $1.07K | <0.1% | +160+8,000.0% | Added | Holders |
| Q2 2024 | 2 | $15 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2 | $20 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2 | $20 | <0.1% | −63−96.9% | Reduced | Holders |
| Q3 2023 | 65 | $497 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 65 | $486 | <0.1% | +65 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −29−100.0% | Sold out | Holders |
| Q4 2022 | 29 | $224 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 29 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 29 | $0 | 0.0% | +29 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −151−100.0% | Sold out | Holders |
| Q4 2021 | 151 | $3.00K | <0.1% | −249−62.3% | Reduced | Holders |
| Q3 2021 | 400 | $9.00K | <0.1% | +400 | New | Holders |